市场调查报告书
商品编码
1465952
全球透析器市场:按类型、薄膜材料、超过滤係数、配置、最终用户 - 2024-2030 年预测Dialyzer Market by Type, Membrane Material, Ultrafiltration Coefficient, Configuration, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年全球透析器市场规模为119.8亿美元,预计2024年将达126.5亿美元,2030年将达176.2亿美元,复合年增长率为5.66%。
透析器的世界也被称为人工肾,它通过去除废物和多余的水来净化血液。
主要市场统计 | |
---|---|
基准年[2023] | 119.8亿美元 |
预测年份 [2024] | 126.5亿美元 |
预测年份 [2030] | 176.2亿美元 |
复合年增长率(%) | 5.66% |
全球透析器市场由製造、分销和销售用于肾衰竭患者透析过程的透析器全球设备的公司组成。全球慢性肾臟病(CKD)和末期肾病(ESRD)等肾臟疾病的盛行率不断上升,推动了对透析治疗的需求。提供卓越性能和患者舒适度的透析设备创新本质上正在扩大市场。新兴国家医疗基础设施的改善和医疗便利性也有助于市场扩张。然而,与透析程序和透析设备相关的高成本对医疗保健提供者和患者来说都是负担。新透析器世界的严格监管和核准流程可能会阻碍市场成长和创新。此外,近期新兴市场的开拓带动了市场的扩张,透过家用可携式透析设备、可穿戴式透析技术的进步以及生物人工透析技术,为满足患者友好且高效的肾臟替代治疗日益增长的需求创造了可能性。此外,数位技术的整合预计将有助于患者监测和提供个人化肾臟疾病治疗的市场成长。
类型:由于高效率,高助焊剂透析器越来越偏好
高助焊剂透析器世界推荐给需要高效率去除毒素(例如中等分子)的患者。高助焊剂透析器的世界具有较大的孔径和优异的渗透性,使其成为清除需求较高的血液透析机患者的首选,以及高效、高助焊剂血液透析机和过滤等治疗的选择也有很多。低助焊剂透析器非常适合需要维持性血液透析机(重点是小分子清除)的患者。低流量透析膜的特征是孔径小、透水性低,导致液体清除速度慢,适合心血管系统不稳定的患者。蛋白质渗漏膜,也称为中型截留膜,是一种新型膜,旨在去除更广泛的尿毒症毒素,同时最大限度地减少白蛋白等有用蛋白质的损失。蛋白质渗漏膜透析器适合需要保存此类蛋白质的患者,并且有可能改善患者的治疗结果。
膜材料:再生纤维素膜的进展以提高生物相容性
醋酸纤维素膜透析器以其卓越的生物相容性和有效去除小分子而闻名。醋酸纤维素膜透析器已被证明能够可靠地去除尿毒症毒素,使其成为低血流量或出现低血压等透析相关症状的患者的首选。与改性的纤维素膜相比,改性纤维素的再生纤维素膜具有更好的生物相容性和更低的过敏反应风险。替换纤维膜透析器的世界是一种由中空纤维形成的合成膜,可为透析提供较大的表面积。它以其高透析效率和耐用性而受到认可,并因能有效去除中、大分子而受到需要高助焊剂透析的患者的青睐。合成膜透析器使用聚砜、聚醚砜和聚丙烯腈。世界合成膜透析器具有优异的生物相容性和机械强度,有效清除各种尿毒症毒素。
超过滤係数:应选择超过滤係数低的薄膜。
高效透析器的设计具有较高的超过滤係数 (Kuf),通常为 20mL/h/mmHg 或更高,这样可以在给定的时间内过滤更多的液体。高效透析器对于需要短期、密集透析或需要在有限时间内去除大量液体或溶质的患者特别有利。低过滤係数透析器是透析器领域中Kuf为10mL/h/mmHg或更低的一类,用于心血管系统不稳定、需要更逐步排出液体的患者,以及因血压升高而导致的低血压患者。较低的超过滤率可以更逐步地去除水分,并减少透析治疗期间低血压的可能性。
组成:提高扁平式透析器在世界各地肾臟病渐进透析的使用率
平板透析器专为对中空纤维透析器体外体积敏感的患者而设计,用于需要精确超过滤控制的场合。对于血流受限、需要温和透析的肾臟疾病患者,通常首选平板透析器。中空纤维透析器具有细小的中空合成纤维,血液流经其中,透析液在纤维外部流动。中空纤维透析器是最常用的透析器世界,其特征是效率高、操作方便、生物相容性高。管式透析器采用螺旋管膜,血液在膜内循环,周围被透析液包围。管式透析器用于患有併发症或特殊医疗状况而无法使用片状滤膜或中空纤维类型的患者。管式透析器可以根据个别患者的需求进行定制,但它们的效率通常低于中空纤维类型。
最终用户:家庭透析治疗设施中的各种应用,以提高舒适度
家庭透析治疗部分针对的是要求并由医疗保健专业人员推荐在家中进行透析治疗的患者。寻求家庭透析治疗的病人需要更多的自主权、舒适度和长期成本节省。此外,透析技术的进步使家用透析设备更易于使用且更紧凑,扩大了家庭透析治疗的可能性。中心透析是指在专门诊所或医院进行的治疗。透析中心的透析适合因病情不稳定、家中无法提供透析环境或纯粹个人喜好而需要更高级治疗的患者。由于透析中心是受控环境,因此如果需要,您可以立即获得医疗护理,医疗专业人员随时待命,并且透析程序按照标准方案进行。
区域洞察
美国和加拿大慢性肾臟病(CKD) 和糖尿病的高盛行率意味着对肾臟护理的需求很高,这推动了这些地区对透析器的全球需求。由于技术进步和强大的医疗基础设施,美洲地区创新透析产品的采用率很高。欧盟 (EU) 国家拥有世界上透析器采用率最高的国家,并有严格的医疗法规和完善的报销制度支持。最近对欧洲各地透析诊所和研究设施的投资显示该市场的稳定成长。在中东国家,影响肾臟健康的文明病呈上升趋势,导致医疗基础设施投资增加。在亚太地区,政府改善医疗保健服务和本地透析产品生产的倡议近年来推动了市场的发展。亚太国家越来越注重国内创新和自力更生,新透析技术专利不断激增,反映出进口替代的趋势。
FPNV定位矩阵
FPNV定位矩阵对于评估全球透析器市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对全球透析器市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、碎片化主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动以及突破性产品开发的智力见解。
1.全球透析器市场规模及预测为何?
2.在全球透析器市场的预测期间内,有哪些产品、细分市场、应用和细分市场需要考虑投资?
3.全球透析器市场的技术趋势和法规结构是什么?
4.全球透析器市场主要厂商的市场占有率为何?
5.进入全球透析器市场的适当型态或策略手段是什么?
[193 Pages Report] The Dialyzer Market size was estimated at USD 11.98 billion in 2023 and expected to reach USD 12.65 billion in 2024, at a CAGR 5.66% to reach USD 17.62 billion by 2030.
A dialyzer is also known as an artificial kidney that purifies the blood by removing waste products and excess fluids, a function that is compromised in individuals with kidney failure.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.98 billion |
Estimated Year [2024] | USD 12.65 billion |
Forecast Year [2030] | USD 17.62 billion |
CAGR (%) | 5.66% |
The dialyzer market comprises companies that manufacture, distribute and sell dialyzer devices used in dialysis processes for patients suffering from renal failure. The rising prevalence of kidney diseases such as chronic kidney diseases (CKD) and end-stage renal disease (ESRD) worldwide fuels the demand for dialysis treatments. Technological innovations in dialysis equipment that offer superior performance and greater patient comfort inherently expand the market. The enhanced healthcare infrastructure and accessibility in developing countries contribute to market expansion. However, high expenses associated with dialysis procedures and equipment can be prohibitive for both healthcare providers and patients. Stringent regulations and approval processes for new dialyzers can hinder market growth and innovation. Moreover, recent developments generate potential for market expansion through portable dialysis devices for home use, advancements in wearable dialyzers, and bioartificial dialysis technologies, all catering to the growing need for patient-friendly and efficient kidney replacement therapies. The integration of digital technologies is also anticipated to contribute market growth for patient monitoring and offering personalized renal disease treatments.
Type: Increasing preference for High-flux dialyzers due to high efficiency
High-flux dialyzers are recommended for patients who require high efficiency in toxin removal, such as middle molecules. High-flux dialyzers have larger pore sizes and more excellent permeability and are often preferred for hemodialysis patients with more significant clearance needs or in treatments such as high-efficiency and high-flux hemodialysis, and hemodiafiltration. Low-flux dialyzers are suitable for patients needing maintenance hemodialysis, focusing on small molecule clearance. Low-flux dialyzers are characterized by smaller pore sizes and lower permeability, which makes them well-suited for patients with cardiovascular instability as they allow for slower fluid removal. Protein-leaking membrane dialyzers, also known as medium cut-off dialyzers, are a newer class designed to remove a wider range of uremic toxins while minimizing the loss of useful proteins such as albumin. Protein-leaking membrane dialyzers are suitable for patients for whom preserving such proteins is critical, potentially improving patient outcomes.
Membrane Material: Advancements in regenerated cellulose membranes for better biocompatibility
Acetate cellulose membrane dialyzers are known for good biocompatibility and allow for the efficient removal of small molecules. Acetate cellulose membrane dialyzers are preferred for patients with low blood flow rates or those who experience dialysis-related symptoms such as hypotension due to their proven capability to provide reliable uremic toxin removal. Regenerated cellulose membranes, produced by the modification of cellulose, provide better biocompatibility compared to unmodified cellulose membranes and have a lower risk of hypersensitivity reactions. Replace fiber membrane dialyzers are synthetic membranes formed by hollow fibers, providing a large surface area for dialysis. Replace fiber membrane dialyzers are recognized for their high efficiency and durability and are preferred for patients requiring high flux dialysis due to their ability to remove middle to large-sized molecules effectively. Synthetic fiber membrane dialyzers utilize polysulfone, polyethersulfone, and polyacrylonitrile. Synthetic fiber membrane dialyzers offer superior biocompatibility and mechanical strength and effectively clear a wide range of uremic toxins.
Ultrafiltration Coefficient: Need based preference for low ultrafiltration coefficient dialyzer
High-efficiency dialyzers are designed to have a high ultrafiltration coefficient (Kuf), typically above 20 mL/h/mmHg, allowing a greater fluid volume to be filtered within a given time. High-efficiency dialyzers are particularly advantageous for patients requiring short but intensive dialysis sessions and when there is a need to remove a large volume of fluid or solutes over a limited time. Low Ultrafiltration Coefficient Dialyzer is a category of dialyzer with a Kuf below 10 mL/h/mmHg, often utilized for patients who require gentler fluid removal due to cardiovascular instability or those with a high risk for dialysis-induced hypotension. The lower ultrafiltration rate allows for more gradual removal of fluids, reducing the potential for hypotensive episodes during dialysis treatment.
Configuration: Rising utilization of Flat-type dialyzers for gentle dialysis in renal disease conditions
Flat type dialyzers are designed for patients who might be sensitive to the larger extracorporeal volume of hollow fiber dialyzers and are used in scenarios where precise control over ultrafiltration is required. Flat-type dialyzers are generally preferred when there is limited blood flow, necessitating gentle dialysis in renal disease conditions. Hollow fiber dialyzers contain tiny, hollow synthetic fibers through which blood flows, while dialysate flows around the outside of the fibers. Hollow fiber dialyzers are the most commonly used type of dialyzers, offering high efficiency and easy handling and have a high biocompatibility profile. Tube-type dialyzers utilize a coiled tubular membrane through which blood circulates internally, surrounded by the dialysate. Tube-type dialyzers are used when the patient presents complications or specific medical conditions that prevent using flat or hollow fiber types. Tube-type dialyzers may be customized to meet individual patient needs, although they are generally less efficient than the hollow fiber design.
End-User: Diverse applications in home dialysis facilities for increased comfort
The home dialysis segment caters to patients who prefer, and are recommended by healthcare professionals, to undergo dialysis treatment at home. Need-based preference for home dialysis typically arises from the patient's desire for increased autonomy, comfort, and potential cost savings over the long term. Moreover, advances in dialysis technology have made home dialysis machines more user-friendly and compact, expanding the accessibility of home treatment. In-center dialysis refers to treatments that take place in specialized clinics or hospital settings. In-center dialysis caters to patients who require a higher level of care, possibly due to unstable medical conditions, lack of a suitable home environment, or simply personal preference. The controlled environment of dialysis centers allows for immediate medical attention if required, and the presence of healthcare professionals ensures that dialysis procedures follow standard protocols.
Regional Insights
In the Americas region, the United States, and Canada, the high prevalence of chronic kidney disease (CKD) and diabetes lead to significant kidney care needs, significantly driving demand for dialyzers in the region. With technological advancements and robust healthcare infrastructure, the Americas region exhibits a strong adoption rate for innovative dialysis products. European Union (EU) countries demonstrate a high adoption rate of dialyzers, backed by stringent healthcare regulations and a well-established reimbursement system. Recent investments in dialysis clinics and research facilities across European countries indicate steady growth in the market space. The Middle East countries are witnessing a growing prevalence of lifestyle-related diseases affecting kidney health, leading to increased investments in healthcare infrastructure in the region. In the APAC region, the government's efforts to improve healthcare access and local manufacturing of dialysis products have propelled the market in recent years. The increasing focus on domestic innovation and self-reliance in the APAC countries showcases a surge in patents related to novel dialysis technologies, reflecting a trend towards import substitution.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Dialyzer Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dialyzer Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Dialyzer Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Allmed Medical Care Holdings Limited, Asahi Kasei Corporation, AWAK Technologies, B. Braun SE, Bain Medical Equipment (Guangzhou) Co., Ltd, Baxter International, Inc., Browndove Healthcare Pvt. Ltd., Cantel Medical Corporation, Dialife SA, Farmasol Medical Products Ind. and Trd. Co., Fresenius Medical Care AG & Co. KGaA, Lepu Medical Technology(Beijing)Co.,Ltd., Medica Trading LLC, Medtronic PLC, Nikkiso Co., Ltd., Nipro Corporation, Poly Medicure Ltd., Sb-Kawasumi Laboratories, Inc., Shandong Weigao Group Medical Polymer Company Limited, and Toray Industries, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Dialyzer Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dialyzer Market?
3. What are the technology trends and regulatory frameworks in the Dialyzer Market?
4. What is the market share of the leading vendors in the Dialyzer Market?
5. Which modes and strategic moves are suitable for entering the Dialyzer Market?